CelestyxAI scientific direction 2025–2026: from AI triage concept to governed intake infrastructure
A project synthesis connecting CelestyxAI's design evolution with the external evidence that now shapes its architecture and validation plan.
The project has progressively narrowed the role of generative AI while strengthening the surrounding clinical control system. That direction is consistent with the emerging literature: workflow-specific evaluation, deterministic tools for formalizable tasks, layered safety, professional control, traceability and standards-based interoperability.
What changed
Early exploration considered broader triage automation. Institutional discovery redirected the product toward professional-facing intake and pre-assessment support: the professional validates or changes the result, and the system does not claim autonomous diagnosis or autonomous clinical decision authority.
What became invariant
The design now treats explicit clinical policy, versioning, auditability, bounded model use, structured outputs, data minimization and professional validation as core invariants rather than optional implementation details.
Next scientific question
The key question is no longer whether an LLM can answer medical questions. It is whether this architecture improves intake completeness, consistency, time and safety in a real supervised workflow without creating new cognitive, governance or integration burdens.
This brief is a CelestyxAI synthesis of the cited external evidence and accumulated project design decisions. It is not a peer-reviewed scientific publication and does not establish clinical efficacy.